Effect of changing s.c. epoetin alfa administration from thrice weekly to once weekly in hemodialysis patients.
To
Linh L
LL
Department of Pharmacy (119), VA San Diego Healthcare System, 3350 La Jolla Village Drive, San Diego, CA 92161, USA. linh.to@med.va.gov
Stoner
Carol P
CP
D000328:Adult; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology*; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects*; D012189:Retrospective Studies; D018709:Statistics, Nonparametric; D016896:Treatment Outcome
D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa